Cargando…

Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis

Tumour-infiltrating lymphocytes (TILs) are regarded as significant prognostic markers in patients with breast cancer. However, the prognostic utility of TIL expression based on the intrinsic subtypes has just been identified. The present study investigated the relationship between TIL grades and pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurozumi, Sasagu, Matsumoto, Hiroshi, Kurosumi, Masafumi, Inoue, Kenichi, Fujii, Takaaki, Horiguchi, Jun, Shirabe, Ken, Oyama, Tetsunari, Kuwano, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396218/ https://www.ncbi.nlm.nih.gov/pubmed/30867728 http://dx.doi.org/10.3892/ol.2019.9938

Ejemplares similares

Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Clinicopathological values of PD-L1 expression in HER2-positive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2018)

ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab
por: Kurozumi, Sasagu, et al.
Publicado: (2015)

Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index
por: Kurozumi, Sasagu, et al.
Publicado: (2017)

Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
por: Kurozumi, Sasagu, et al.
Publicado: (2016)

Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
por: Honda, Chikako, et al.
Publicado: (2021)

The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy
por: Nakazawa, Yuko, et al.
Publicado: (2020)

Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70‐interacting protein in postmenopausal breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2016)

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2022)

Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer
por: Handa, Tadashi, et al.
Publicado: (2019)

Phase II study of sequential S-1 and cyclophosphamide therapy in patients with metastatic breast cancer
por: Yanai, Keiko, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG-PET to predict the tumour immune status defined by tumoural PD-L1 and CD8(+)tumour-infiltrating lymphocytes in oral squamous cell carcinoma
por: Togo, Maria, et al.
Publicado: (2020)

Process of distant lymph node metastasis in colorectal carcinoma: Implication of extracapsular invasion of lymph node metastasis
por: Fujii, Takaaki, et al.
Publicado: (2011)

Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2021)

Adenocarcinoma of Ascending Colon Associated with Sarcoid Reaction in Regional Lymph Nodes
por: Fujii, Takaaki, et al.
Publicado: (2010)

Oestrogen receptor-α variant mRNA expression in primary human breast tumours and matched lymph node metastases
por: Leygue, E, et al.
Publicado: (1999)

FDG-PET/CT of schwannomas arising in the brachial plexus mimicking lymph node metastasis: report of two cases
por: Fujii, Takaaki, et al.
Publicado: (2014)

Extracapsular Invasion of Sentinel Lymph Nodes Is Not Associated With Disease Recurrence in Breast Cancer
por: Fujii, Takaaki, et al.
Publicado: (2014)

Neuroendocrine tumor of the ampulla of Vater with distant cystic lymph node metastasis: a case report
por: Tsukagoshi, Mariko, et al.
Publicado: (2016)

Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis
por: Kim, Sun A, et al.
Publicado: (2016)

RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive miR‐101‐5p regulates molecular pathogenesis
por: Toda, Hiroko, et al.
Publicado: (2019)

FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma
por: Miyazaki, T, et al.
Publicado: (2003)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
por: Kunisue, H, et al.
Publicado: (2000)

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
por: West, N R, et al.
Publicado: (2013)

Oestrogen Metabolism in Cultured Human Breast Tumours
por: Willcox, P. A., et al.
Publicado: (1972)

Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators
por: Inoue, Kenichi, et al.
Publicado: (2018)

Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer
por: Kamai, Takao, et al.
Publicado: (2010)

Fibrocystic breast disease with pleomorphic calcifications and segmental distribution: A case report
por: JiueLan, Kuo, et al.
Publicado: (2023)

Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
por: Rosin, G, et al.
Publicado: (2014)

Absence of Granzyme B Positive Tumour-Infiltrating Lymphocytes in Primary Melanoma Excisional Biopsies is Strongly Associated with the Presence of Sentinel Lymph Node Metastasis
por: van Houdt, I. S., et al.
Publicado: (2009)

Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma
por: dos Santos, Fernando De Marco, et al.
Publicado: (2019)

Human regional tumour lymph nodes: alterations of micro-architecture and lymphocyte subpopulations.
por: Eremin, O., et al.
Publicado: (1980)

Retroperitoneal lymph node dissection for germ cell tumour
por: Tran, Vy, et al.
Publicado: (2020)

Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression
por: Hanamura, Toru, et al.
Publicado: (2022)

Automated classification of fat-infiltrated axillary lymph nodes on screening mammograms
por: Song, Qingyuan, et al.
Publicado: (2023)

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer
por: Sakae, Chieko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qt1gr5ib6ifbcvomj457hja939